| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 465-472, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
N Patey, R Vazeux, D Canioni, T Potter, WM Gallatin and N Brousse
Service d'Anatomie et de Cytologie Pathologiques, Hopital Necker- Enfants Malades, Paris, France.
Intercellular adhesion molecule-3 (ICAM-3) was identified as the third counter-receptor for lymphocyte function-associated antigen-1. ICAM-3 is absent on endothelial cells in normal tissues but found on endothelial cells in lymphomas. Here, we examined ICAM-3 expression on vascular endothelial cells in lymphomas, nonlymphoid malignancies, benign tumors, and inflammatory diseases. We compared the expression of ICAM-3 on endothelial cells with the severity of inflammatory infiltrates and with the presence of E-selectin and VCAM-1. We found that ICAM-3 expression on endothelial cells was high on both benign and malignant tumors whereas it was low in inflammatory diseases. In contrast to E-selectin, ICAM-3 expression on endothelial cells was not correlated to the severity of inflammatory infiltrates. In hemangiomas, we showed by Northern blot analysis and immunocytochemistry that ICAM-3 expression was induced and that it was localized in immature areas that sustain the early stages of angiogenesis. Therefore, expression of ICAM- 3 on blood vessels does not seem to play a role in the recruitment of leukocytes during inflammation but rather is correlated with angiogenesis and tumor development.
This article has been cited by other articles:
![]() |
T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Steppich, F. Dayyani, R. Gruber, R. Lorenz, M. Mack, and H. W. L. Ziegler-Heitbrock Selective mobilization of CD14+CD16+ monocytes by exercise Am J Physiol Cell Physiol, September 1, 2000; 279(3): C578 - C586. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Heiska, K. Alfthan, M. Gronholm, P. Vilja, A. Vaheri, and O. Carpen Association of Ezrin with Intercellular Adhesion Molecule-1 and -2 (ICAM-1 and ICAM-2). REGULATION BY PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE J. Biol. Chem., August 21, 1998; 273(34): 21893 - 21900. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kessel, J. Hayflick, A. S. Weyrich, P. A. Hoffman, M. Gallatin, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman Coengagement of ICAM-3 and Fc Receptors Induces Chemokine Secretion and Spreading by Myeloid Leukocytes J. Immunol., June 1, 1998; 160(11): 5579 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Shanley, R. L. Warner, L. D. Crouch, G. N. Dietsch, D. L. Clark, M. M. O'Brien, W. M. Gallatin, and P. A. Ward Requirements for {alpha}d in IgG Immune Complex-Induced Rat Lung Injury J. Immunol., January 15, 1998; 160(2): 1014 - 1020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |